Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased thromboxane biosynthesis in type IIa hypercholesterolemia.

G Davì1, M Averna, I Catalano

  • 1Department of Medicine, University of Palermo School of Medicine, Italy.

Circulation
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of a Laboratory Index of Frailty in Older Patients Hospitalized for COVID-19: The COMEPA Study.

The Journal of frailty & aging·2024
Same author

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

Radiation research·2023
Same author

RENEB Inter-Laboratory Comparison 2021: The Cytokinesis-Block Micronucleus Assay.

Radiation research·2023
Same author

RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

Radiation research·2023
Same author

A NOVEL BIOLOGICAL DOSIMETRY ASSAY AS A POTENTIAL TOOL FOR TRIAGE DOSE ASSESSMENT IN CASE OF LARGE-SCALE RADIOLOGICAL EMERGENCY.

Radiation protection dosimetry·2019
Same author

Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post-PRECISION: What We Thought We Knew Then and What We Think We Know Now.

Clinical pharmacology and therapeutics·2017
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Platelet thromboxane A2 (TXA2) biosynthesis is elevated in type IIa hypercholesterolemia, linked to high cholesterol. Low-dose aspirin effectively reduces TXA2 metabolite excretion, indicating TXA2-dependent platelet activation.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Pharmacology

Background:

  • Platelet thromboxane A2 (TXA2) production is reportedly increased in type IIa hypercholesterolemia.
  • This study investigates the in vivo relevance of TXA2 production by measuring urinary metabolites.

Purpose of the Study:

  • To assess in vivo thromboxane A2 (TXA2) biosynthesis in type IIa hypercholesterolemia.
  • To correlate TXA2 metabolite excretion with cholesterol levels and platelet function.
  • To evaluate the effect of simvastatin and aspirin on TXA2 production.

Main Methods:

  • Measured urinary 11-dehydro-TXB2 and 2,3-dinor-TXB2 in 46 hypercholesterolemia patients and 20 controls using radioimmunoassays.
  • Correlated metabolite excretion with collagen/arachidonate aggregation thresholds, in vitro platelet TXB2 production, and plasma cholesterol.

Related Experiment Videos

  • Assessed effects of simvastatin and low-dose aspirin on urinary TXA2 metabolites.

    • Main Results:

    • Urinary 11-dehydro-TXB2 excretion was significantly higher in patients (68.7 ng/hr) vs. controls (22.4 ng/hr), with 74% of patients exceeding normal levels.
    • Excretion correlated with platelet aggregation sensitivity, in vitro TXB2 production, and total plasma cholesterol.
    • Simvastatin reduced cholesterol and TXA2 metabolites, but reductions were not correlated.
    • Low-dose aspirin inhibited 11-dehydro-TXB2 excretion by approximately 70%.

    Conclusions:

    • Enhanced TXA2 biosynthesis occurs in most type IIa hypercholesterolemia patients.
    • Elevated TXA2 production is partly due to abnormal cholesterol levels.
    • Low-dose aspirin effectively suppresses increased TXA2 metabolite excretion, confirming TXA2-dependent platelet activation in vivo.